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Respiratory syncytial virus (RSV)-induced chemokine gene expression occurs through the activation of a subset of transcription factors,
including Interferon Regulatory Factor (IRF)-3. In this study, we have investigated the signaling pathway leading to RSV-induced IRF-3 activation
and whether it is mediated by intracellular reactive oxygen species (ROS) generation. Our results show that RSV infection induces expression and
catalytic activity of IKKε, a noncanonical IKK-like kinase. Expression of a kinase-inactive IKKε blocks RSV-induced IRF-3 serine
phosphorylation, nuclear translocation and DNA-binding, leading to inhibition of RANTES gene transcription, mRNA expression and protein
synthesis. Treatment of alveolar epithelial cells with antioxidants or with NAD(P)H oxidase inhibitors abrogates RSV-induced chemokine
secretion, IRF-3 phosphorylation and IKKε induction, indicating that ROS generation plays a fundamental role in the signaling pathway leading to
IRF-3 activation, therefore, identifying a novel molecular target for the development of strategies aimed to modify the inflammatory response
associated with RSV infection of the lung.
© 2006 Elsevier Inc. All rights reserved.Keywords: RSV; Airway epithelial cells; IRF; ROS; InflammationIntroduction
RSV is an enveloped, negative-sense single-stranded RNA
virus, belonging to the paramyxovirus family. Since its isolation,
RSV has been identified as a leading cause of epidemic
respiratory tract illness in children, in the U.S. and worldwide
(Hall, 2001). RSV induces a broad spectrum of clinical diseases
ranging from otitis media to mild upper respiratory infection,
acute laryngeo-tracheo-bronchitis, or more severe lower respi-
ratory tract infections. In young children (1 month–2 years old),⁎ Corresponding author. Department of Pediatrics, Child Health Research
Center, 301 University Blvd., Galveston, TX 77555-0366, USA. Fax: +1 409
772 1761.
E-mail address: ancasola@utmb.edu (A. Casola).
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doi:10.1016/j.virol.2006.05.022RSV infection can develop into significant lower respiratory
tract disease, histologically distinguishable into two syndromes:
(1) pneumonia, with diffuse mononuclear inflammation of the
bronchi, bronchioles and interalveolar walls; and (2) bronchi-
olitis, characterized by necrosis of the bronchiolar epithelium,
edema, and mononuclear cell infiltration of the bronchiolar
submucosa with mucus plugs and air trapping (Aherne et al.,
1970; Hall, 1999). Airway epithelial cells are the main targets of
RSV infection. Following inhalation or self-inoculation of the
virus into the nasal mucosa and infection of the local respiratory
epithelium, RSV spreading along the respiratory tract occurs
mainly by cell-to-cell transfer of the virus along the intra-
cytoplasmic bridges (Hall, 1992). Under normal conditions, the
respiratory epithelium is responsible for clearance of inhaled
particulates and maintenance of alveolar patency. However,
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variety of molecules involved in antiviral and innate immune
responses, like interferons, cytokines and chemokines, and
therefore plays a major role in the initial host protective response
to viral infections. A number of molecules have been described
that are produced by human airway epithelial cells as a
consequence of RSV infection. We, as well as others, have
demonstrated that RSV is a potent stimulus for chemokine
production, including interleukin (IL)-8 and RANTES, in
cultured human nasal, bronchial and alveolar epithelial cells
(Saito et al., 1997; Olszewska-Pazdrak et al., 1998; Zhang et al.,
2001). In the past few years, we have characterized the
mechanisms involved in RSV-induced expression of the
chemokines IL-8 and RANTES, whose expression in epithelial
cells require viral replication (Garofalo et al., 1996; Casola et al.,
2000, 2001b). RSV-induced RANTES expression is dependent
on the activation of IRFs, especially IRF-3, which are absolutely
necessary for RANTES promoter induction (Casola et al.,
2001b). We have also shown that ROS are important mediators
of RSV-induced RANTES gene expression, modulating IRF-1,
-3 and -7 activation (Casola et al., 2001a). Treatment of airway
epithelial cells with the antioxidant butylated hydroxyanisol
(BHA) inhibits RSV-induced IRF-1 and -7 gene expression and
protein synthesis (Casola et al., 2001a), through inhibition of
Signal Transducers and Activators of Transcription (STAT)-1
and -3 activation (Liu et al., 2004). BHA treatment also inhibits
IRF-3 nuclear translocation, indicating that a redox-sensitive
pathway is involved in RSV-induced IRF-3 activation (Casola
et al., 2001a). However, the signaling pathway(s) leading to
RSV-induced IRF-3 activation, and whether it is ROS-depen-
dent, is currently not known.
IRF-3 is a constitutively expressed protein, which is
phosphorylated on several serine/threonine residues present on
the C-terminus of the protein, upon viral infection. This event
allows dimerization, nuclear localization and DNA-binding (Lin
et al., 1998). Two separate groups have identified the I kappa B
kinase (IKK)-like molecule IKKε, together with Tank Binding
Kinase (TBK)1, as a critical component of the virus-activated
kinase (VAK) complex responsible for IRF-3 phosphorylation
(Fitzgerald et al., 2003; Sharma et al., 2003). Overexpression of
IKKε induces IRF-3 and -7 nuclear translocation and binding to
Interferon Regulated Responsive Element (ISRE) promoter
sites, leading to the expression IFN-β and RANTES genes
(Fitzgerald et al., 2003; Sharma et al., 2003), following
[(Fitzgerald et al., 2003; Sharma et al., 2003). In this study, we
have investigated the role of IKKε, as well as ROS generation, in
RSV-induced IRF-3 activation. RSV induces IKKε mRNA
expression and protein synthesis, as well as its catalytic activity.
Expression of a kinase-inactive IKKε blocks RSV-induced
RANTES gene transcription, mRNA expression and protein
synthesis. This occurs through inhibition of IRF-3 serine
phosphorylation, an event known to be necessary for viral-
induced nuclear translocation, DNA-binding and activation of
chemokine gene transcription (Lin et al., 1998). Antioxidant
treatment of alveolar epithelial cells inhibits RSV-induced IRF-3
serine phosphorylation and IKKε induction. Moreover, treat-
ment of alveolar epithelial cells with various NAD(P)H oxidaseinhibitors, including diphenylene iodonium (DPI), apocyanin
and aminoethyl benzene sulfonyl fluoride (AEBSF), signifi-
cantly reduces RANTES secretion, IRF-3 phosphorylation and
IKKε induction, indicating that NAD(P)H oxidase-produced
ROS are required for induction of the signaling pathway leading
to IRF-3 activation in viral-infected airway epithelial cells.
Results
RSV infection of airway epithelial cells induces IKKε activation
IKKε is an IKK-like kinase identified as part of a novel
kinase complex which can activate NF-κB following certain
inducers like LPS and PMA (Shimada et al., 1999; Peters et al.,
2000). Recent studies have reported a fundamental role of IKKε
in IRF-3 activation and induction of IRF-3-dependent genes,
like IFN-α4, IFN-β and RANTES (Sharma et al., 2003;
Fitzgerald et al., 2003). Expression of IKKε can be either
constitutive or inducible, depending on the cell type (Shimada
et al., 1999). To investigate whether RSV infection of A549
cells induced IKKε expression, we performed Western blot
analysis of total cell lysates prepared from A549 cells
uninfected or infected for various lengths of time. As shown
in Fig. 1A, RSV infection caused a marked increase in IKKε
protein synthesis, starting around 6 h post-infection (p.i.) and
peaking at 12 h. To determine whether IKKε protein synthesis
was paralleled by changes in steady-state level of its mRNA,
total RNA was extracted from cells uninfected and infected for
various length of time, and used to amplify IKKε gene by RT-
PCR (Olszewska-Pazdrak et al., 1998). As shown in Fig. 1B,
RSV-induced IKKε gene expression followed a kinetic similar
to the one seen for protein induction, with up-regulation
occurring between 6 and 12 h p.i.
We then asked whether RSV-induced IKKε was catalytically
active and could phosphorylate IRF-3. For this purpose, we
performed kinase assays using IKKε immunoprecipitated from
A549 cell uninfected or infected with RSV for various lengths
of time and an IRF-3 peptide corresponding to amino acids
380–406, which contains the major viral-inducible phosphor-
ylation sites (Lin et al., 1998), as substrate. As shown in Fig. 1C,
IKKε catalytic activity was significantly increased, following
viral infection, starting at 6 h p.i., with maximal activity at 12 h.
This pattern is similar to the kinetics of RSV-induced IRF-3
nuclear translocation and DNA binding, as well as to the
kinetics of RSV-induced RANTES gene expression (Casola
et al., 2001a).
Viral-induced IRF-3 activation occurs through phosphoryl-
ation of specific C-terminal serine residues, located between
amino acids 386 and 405 (Lin et al., 1998), of which Ser396 has
been shown to be necessary for viral-induced IRF-3 activation
(Servant et al., 2003). To determine whether IRF-3 was
phosphorylated following RSV infection, cytoplasmic and
nuclear extracts were prepared from A549 cells uninfected or
infected for various length of time and used for Western blot
analysis of Ser396 phosphorylated IRF-3. As shown in Fig. 1D,
RSV infection induced IRF-3 phosphorylation both in the
cytoplasmic and nuclear compartment, starting at 6 h p.i. and
Fig. 1. RSV infection induces IKKε activation in A549 cells. Panel A: IKKε
protein levels. Total cell lysates, prepared from A549 cells uninfected or infected
with RSV for 6, 12 and 24 h, were resolved on 10% SDS-PAGE and Western
blot was performed using an anti-IKKε antibody. Membrane was stripped and
reprobed for β-actin. Panel B: IKKεmRNA. A549 cells were infected with RSV
for various lengths of time (hours). Total RNA was extracted from control and
infected cells and used to amplify IKKε by Q-RT-PCR. Panel C: IKKε kinase
activity. Total cell lysates were prepared from uninfected (Ctrl) or RSV-infected
cells for 3, 6, 12 and 24 h. IKKε was immunoprecipitated with a specific
antibody for in vitro kinase assay. Amount of 32P-phosphate incorporated into
the IRF-3 substrate was quantified by exposure to PhosphoImager cassette and
analyzed with Molecular Dynamics Storm imaging system software. Relative
radioactivity is expressed in arbitrary units after subtraction of the background
radioactivity present in the buffer alone sample. Data are representative of one of
two independent experiments. Panel D: kinetics of IRF-3 phosphorylation.
A549 cells were infected with RSV for various lengths of time and harvested to
prepare cytoplasmic (Cyto) and nuclear extracts (NE). Equal amounts of protein
from uninfected and infected cells were analyzed by Western immunoblot
probed with anti Ser396 phospho-IRF-3 antibody. Membrane was stripped and
reprobed for β-actin (cytoplasmic extracts) and lamin b (nuclear extracts).
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formation is similar to RSV-induced IKKε activation, suggesting
that indeed IKKε could play an important role in IRF-3 activation
following RSV infection.
IKKε regulates RSV-induced RANTES promoter activation
through the ISRE site
Since IRF-3 activation plays a fundamental role in RSV-
induced chemokine gene expression (Casola et al., 2001b), we
investigated the effect of overexpressing catalytically inactive
IKKε (mutated on the lysine residue 38 of the catalytic domain
by substitution with alanine and defined as K38A) (Peters et al.,
2000) on RSV-induced RANTES gene transcription. 293 cells
were cotransfected with a construct containing the minimal
RSV-inducible RANTES promoter-luciferase reporter gene,
PGL2-220, and a pcDNA3-based expression plasmid containing
FLAG-tagged IKKεK38A (Casola et al., 2001b). Expression of
the dominant negative mutant IKKε significantly reduced, in a
dose-dependent manner, RSV-induced luciferase activity of the
RANTES promoter construct, indicating a role of this kinase in
viral-induced RANTES gene transcription (Fig. 2A).
RANTES promoter activation, following RSV infection, is
controlled by multiple regulatory elements (Casola et al.,
2001b). Both an intact NF-κB site and ISRE, the IRF binding
site, are important for RSV-stimulated RANTES gene tran-
scription, with the ISRE site being absolutely necessary (Casola
et al., 2001b). To determine whether IKKε activation was
sufficient to induce RANTES transcription and whether this
occurred through the ISRE site, 293 cells were transiently
transfected with a plasmid expressing wild type IKKε and
RANTES promoter plasmids either wild type or containing site-
mutations of the ISRE or the NF-κB binding sites. As shown in
Fig. 2B, overexpression of IKKε caused a significant (∼6-fold)
activation of the RANTES promoter, which was abolished by
mutation of the ISRE site. On the contrary, the RANTES NF-κB
site mutation significantly reduced basal promoter activity, yet
showed a 20-fold induction by IKKε expression (Casola et al.,
2001b). Together these data indicate that IKKε is a potent
activator of the ISRE.
To further confirm that expression of the catalytically
inactive IKKε affected RSV-induced RANTES promoter
activation through the ISRE site, 293 cells were transiently
transfected with a construct containing multiple copies of the
isolated RANTES ISRE site linked to the luciferase reporter
gene (Casola et al., 2002), and the IKKε K38A plasmid.
Expression of IKKε K38A caused a significant inhibition,
between 70 and 80%, of IRF-driven transcription (Fig. 2C).
This effect was specific to IKKε since expression of catalytically
inactive (DN) IKKβ only modestly reduced RSV-induced ISRE
activation (Fig. 2C).
IKKε regulates RSV-induced RANTES gene expression and
IRF-3 phosphorylation
To further investigate the role of IKKε in transcription factor
activation and gene expression following RSV infection, we
Fig. 2. Effect of overexpressing catalytically-inactive or wild type IKKε on
RANTES transcription. Panel A: 293 cells were transfected with the PGL2-220
RANTES promoter and the pcDNA3-IKKε K38A plasmid or the empty vector
at different indicated concentrations, and infected with RSV. Cells were
harvested 24 h post-infection to measure luciferase activity. Uninfected plates
served as controls. For each plate luciferase was normalized to the β-
galactosidase reporter activity. Data are expressed as mean ± standard deviation
of normalized luciferase activity. Panel B: 293 cells were transfected with the
PGL2-220 RANTES promoter wild type (WT) or mutated in the ISRE (ΔISRE)
or NF-κB (ΔNF-κB) site and the pcDNA3-IKKε wild type (WT) or the empty
vector (EV). Cells were harvested 48 h later to measure luciferase activity. Panel
C: 293 cells were transiently transfected with multimers of the RANTES ISRE
site and either the pcDNA3-IKKε K38A plasmid or a kinase-inactive (DN)
IKKβ expression plasmid and infected with RSV. Cells were harvested 12 h
post-infection to measure luciferase activity. Uninfected plates served as
controls. For each plate luciferase was normalized to the β-galactosidase
reporter activity. Data are expressed as mean ± standard deviation of normalized
luciferase activity.
158 H. Indukuri et al. / Virology 353 (2006) 155–165established 293 stable cell lines expressing K38A FLAG-tagged
IKKε, under the control of a tetracycline-regulated promoter. As
a control cell line, we used a clone containing the empty vector
(EV) only. To induce IKKε expression, the stable tetracycline
derivative doxycycline (Dox) was added to the culture medium
and IKKε protein level was monitored at different time points
thereafter by Western blot using an anti-FLAG antibody. As
shown in Fig. 3, there was a time-dependent expression of
IKKε, which was maximal at 48 h following Dox treatment
(further time points not shown). We next sought to confirm the
role of IKKε in RSV-induced RANTES gene expression by
investigating RANTES protein and mRNA induction following
RSV infection of the K38A-expressing 293 cell line. Cells were
treated with Dox for 48 h, infected with RSV for 24 h and
harvested to measure RANTES protein by ELISA and
RANTES mRNA by Northern blot (Casola et al., 2001a).
Expression of kinase-inactive IKKε significantly blocked viral-
induced RANTES secretion (Fig. 4A), as well as mRNA
induction (Fig. 4B), indicating a fundamental role of IKKε in
the expression of this viral-induced chemokine. A similar
inhibition was observed for RSV-induced production of IFN-β,
whose gene expression is regulated similarly to the RANTES
gene (data not shown) (Wathelet et al., 1998).
Furthermore, to determine whether inhibition of IKKε
activation would block RSV-induced IRF-3 activation, we
measured phospho Ser396 IRF-3 formation in 293 cells
expressing IKKε K38A. Nuclear extracts were prepared from
control (EV) or IKKε K38A (DN) expressing 293 cells infected
with RSV for various lengths of time and used for Western blot
analysis of phospho Ser396 IRF-3. As shown in Fig. 4C,
expression of catalytic-inactive IKKε significantly blocked
viral-induced IRF-3 phosphorylation, indicating that IKKε
plays a fundamental role in RSV-induced IRF activation.
ROS regulate viral-induced IRF-3 activation
We have previously shown that RSV infected airway
epithelial cells generate ROS and that antioxidant treatment
with butylated hydroxyanisole (BHA), as well as a panel of
chemically unrelated antioxidants, blocks RSV-induced signal
transduction cascade leading to chemokine expression in vitro,
through inhibition of transcription factors belonging to IRF and
Signal Transducers and Activators of Transcription (STAT)ig. 3. Kinetics of catalytically inactive IKKε expression in 293 stable cell line.
93 stable cell lines IKKε K38Awere treated with Dox for 12, 24 and 48 h and
arvested to prepare total cell lysates. Equal amounts of protein from uninfected
nd infected cells were assayed by Western blot for FLAG-IKKε expression.
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Fig. 5. Effect of antioxidant treatment on RSV-induced IRF-3 and IKKε
activation. Panel A: IRF-3 phosphorylation. Nuclear extracts were prepared
from A549 cells control and infected with RSV for 12 and 24 h, in the absence or
presence of 400 μM BHA, and assayed for Ser396 phosphorylation by Western
blot. Membrane was stripped and reprobed for lamin b to control the equal
loading of the samples. Panel B: IKKε mRNA. A549 cells were infected with
RSV for 24 h, in the absence or presence of 400 μM BHA. Total RNA was
extracted from control and infected cells and used to amplify IKKε by Q-RT-
PCR. Panel C: IKKε protein levels. Total cell lysates, prepared from A549 cells
control and infected with RSV for 24 h, in the absence or presence of 400 μM
BHA, were resolved on 10% SDS-PAGE and Western blot was performed using
an anti-IKKε antibody. Membrane was stripped and reprobed for β-actin.
Fig. 4. Expression of catalytically inactive IKKε blocks viral-induced RANTES
expression and IRF-3 phosphorylation. Panel A: RANTES protein secretion.
293 control cell line (EV) and IKKε K38A cell line (DN) were treated with
tetracycline for 48 h and then infected with RSV. Culture supernatants, from
uninfected (Ctrl) and infected (RSV) cells, were assayed 24 h later for RANTES
production by ELISA. Data are expressed as mean ± standard deviation of
triplicate samples. Panel B: RANTES mRNA induction. Total RNA was
extracted from control (C) and 24 h infected (V) cells. Twenty micrograms of
RNA were fractionated on a 1.2% agarose-formaldehyde gel, transferred to
nylon membrane and hybridized to a radiolabeled RANTES cDNA probe.
Membrane was stripped and hybridized with a radiolabeled β-actin probe, to
show equal loading of the samples. Panel C: IRF-3 phosphorylation. Control and
IKKε K38A 293 cell lines were infected with RSV for 6, 12 and 24 h and
harvested to prepare nuclear extracts. Equal amounts of protein from uninfected
and infected cells were fractionated on a 10% SDS-PAGE, transferred to PVDF
membrane and probed with anti Ser396 phospho-IRF-3 antibody. Membrane
was stripped and reprobed for lamin b to control the equal loading of the
samples.
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blocks RSV-induced IRF-1 and -7 gene expression and inhibits
IRF-3 nuclear translocation and DNA binding to the RANTES
Interferon Stimulated Responsive Element (ISRE), an event that
is absolutely required for RSV-stimulated RANTES gene
transcription. To determine whether antioxidant treatment
inhibits RSV-induced IRF-3 activation, we examined RSV-
induced IRF-3 serine phosphorylation in A549 cells treated with
400 μM BHA. A549 cells were infected with RSV in the
presence or absence of BHA and harvested at 12 and 24 h p.i. to
extract nuclear proteins for Western blot analysis of phosphorSer396 IRF-3. As shown in Fig. 5A, antioxidant treatment
completely blocked RSV-induced IRF-3 phosphorylation,
indicating that it is redox-dependent.
Since IKKε plays a major role in RSV-induced IRF-3
activation, we examined IKKε gene expression and protein
synthesis in A549 cells infected with RSV in the presence or
absence of the antioxidant. As shown in Fig. 5B, RSV-induced
IKKε gene expression was significantly inhibited by antioxidant
treatment. Similar results were obtained when we examined
IKKε protein synthesis, which was strongly induced by RSV
infection and abolished by antioxidant treatment (Fig. 5C).
An important source of inducible intracellular ROS, ge-
nerated in response to a variety of stimuli, is the membrane-
bound NAD(P)H oxidase system [Reviewed in (Babior, 1999)].
We have previously shown that treatment of A549 cells with
DPI, a known NAD(P)H oxidase inhibitor, significantly
160 H. Indukuri et al. / Virology 353 (2006) 155–165blocked RSV-induced STATactivation (Liu et al., 2004). To test
if RSV-induced IRF-3 activation was mediated through ROS
production by this enzyme complex, A549 cells were treated
with various NAD(P)H oxidase inhibitors, including DPI,
apocyanin and AEBSF (Schwarzer et al., 2004), and infected
with RSV for 24 h. We then assessed RSV-induced RANTES
production and IRF-3 phosphorylation. As shown in Fig. 6A, all
three inhibitors significantly reduced RANTES secretion, as
well as IRF-3 phosphorylation (Fig. 6B). DPI almost completely
abolished RSV-induced IKKε gene expression (Fig. 6C), with alimited effect on viral replication (Fig. 6D), indicating that the
NAD(P)H oxydase system is important for the generation of
ROS and subsequent activation of IRF-3 following RSV
infection.
Discussion
The innate immune response represents a critical compo-
nent of the host defense against viruses and is coordinated at
the cellular level by activation of transcription factors that
regulate the expression of inducible gene products with
antiviral and/or inflammatory activity. RSV is the most
common cause of epidemic respiratory infections in infants
and young children and represents the prototype of mucosal-
restricted viral pathogens with epithelial cell tropism and
profound proinflammatory activity. RSV replication in airway
epithelial cells results in the activation of multiple cellular
signaling pathways involved in the expression of early
response genes, which is coordinated by a small subset of
transcription factors including NF-κB and IRF proteins
(Garofalo et al., 1996; Casola et al., 2000, 2001b; Tian et
al., 2002). Most of the signaling pathways leading to RSV-
induced gene expression are still unknown. Free radicals and
ROS have recently been shown to function as second
messengers influencing a variety of molecular and biochemical
processes, including expression of a number of genes
[Reviewed in (Allen and Tresini, 2000)]. In earlier studies,
we have shown that ROS play a major role in RSV-induced de
novo IRF-1 and -7 genes expression and protein synthesis, by
regulating STAT-1 and -3 activation (Casola et al., 2001a; Liu
et al., 2004). We have also shown that inhibition of ROS
production, by antioxidant treatment, blocks IRF-3 nuclear
translocation and DNA binding to the RANTES ISRE site
(Casola et al., 2001a). However, the intracellular signaling
events leading to RSV-induced IRF-3 activation and the
mechanism of inhibition of IRF-3 induction by antioxidant
treatment were not investigated. In this study, we show that
RSV infection of airway epithelial cells induces activation of
IKKε, a noncanonical IKK-like molecule, recently identified
as an essential component of the virus activated kinase (VAK)
complex responsible for IRF-3 activation. Expression of
catalytically inactive IKKε significantly inhibits RSV-inducedFig. 6. Effect of NADPH inhibition on RSV-induced IRF-3 and IKKε activation.
Panel A: RANTES secretion. A549 cells were infected with RSV for 24 h, in the
absence or presence of either 10 μMDPI, 500 μMAEBSF or 500 μM apocyanin
(Apo). Culture supernatants were assayed 24 h later for RANTES production by
ELISA. Data are expressed as mean ± standard deviation of triplicate samples.
Panel B: IRF-3 phosphorylation. Nuclear extracts were prepared from A549
cells control and infected with RSV for 24 h, in the absence or presence of either
10 μM DPI, 500 μM AEBSF or 500 μM apocyanin (Apo) and assayed for
Ser396 phosphorylation by Western blot. Membrane was stripped and reprobed
for total IRF-3 and for lamin b to control the equal loading of the samples. Inh:
inhibitor. Panel C: IKKεmRNA. A549 cells were infected with RSV for 24 h, in
the absence or presence of 10 μM DPI. Total RNA was extracted from control
and infected cells and used to amplify IKKε by Q-RT-PCR. Panel D: viral
replication. A549 cells were infected with RSV, in the absence or presence of
10 μM DPI. Cell culture supernatants were harvested at 24 h post-infection and
viral load was determined by plaque assay.
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tion and ISRE-driven transcription, through the inhibition of
IRF-3 phosphorylation, indicating a fundamental role of this
kinase in the pathway leading to RSV-induced IRF-3
activation. We also show that RSV-induced ROS formation,
occurring likely through the NAD(P)H oxidase system, is
involved in RSV-induced IKKε activation, as indicated by the
inhibition of IKKε expression and IRF-3 phosphorylation by
antioxidant treatment, as suggested in the schematic model of
Fig. 7.
IKKε was originally cloned as a component of a distinct
IκB kinase complex, separate from the canonical one contain-
ing IKKα and IKKβ, that mediates NF-κB activation
following certain inducers like LPS and phorbol ester
(Shimada et al., 1999; Peters et al., 2000). However, recent
findings have revealed a fundamental role of IKKε, and the
similar IKK-like kinase Tank Binding Kinase (TBK)1, in the
signaling pathway leading to IRF-3 activation (Fitzgerald et al.,
2003; Sharma et al., 2003; Hemmi et al., 2004; Perry et al.,
2004). Both kinases have been shown to be important for
double-stranded RNA and viral-induced IRF-3 phosphoryla-
tion and expression of IRF-3 dependent genes, while TBK1,
but not IKKε, seems to be required for LPS-induced IRF-3
activation (Hemmi et al., 2004; Perry et al., 2004; TenOever
et al., 2004).
While TBK1 is constitutively and ubiquitously expressed,
expression of IKKε can be induced, in a cell type-dependent
manner (Shimada et al., 1999). Splenocytes and thymocytes
show constitutive expression of IKKε, while IKKε mRNA can
be upregulated in macrophages and cells isolated from the
synovia following cytokines, LPS or PMA stimulation
(Shimada et al., 1999; Aupperle et al., 2001). Here, we show
that IKKε expression is inducible in airway epithelial cells
infected with RSV. The only another report of IKKε induction
following a viral infection, is in mouse embryonic fibroblasts
infected with Vesicular Stomatitis Virus (VSV) (TenOever et al.,
2004). The mechanism(s) regulating IKKε gene expression is
not known, however cytokines, LPS, PMA and viruses are all
potent activators of NF-κB, therefore it is likely that this master
transcriptional regulator plays an important role in IKKεFig. 7. Schematic representation of the proposed role of ROS in viral-induced
IKKε and IRF-3 activation.induction. In support of this hypothesis is the lack of IKKε
gene expression in LPS-stimulated MEFs which are deficient in
the expression of IKKβ, the kinase that controls NF-κB
activation following a variety of different stimuli, including
viral infections (Chu et al., 1999; Delhase et al., 1999; Israel,
2000).
In our study, the kinetics of IKKε kinase activity correlates
with its expression. It has been previously shown that
recombinant IKKε is phosphorylated during its expression
and that this phosphorylation is necessary for kinase activity
(Shimada et al., 1999; Kishore et al., 2002). Once the kinase is
present, its enzymatic activity cannot be further stimulated by
agonist treatment, suggesting that IKKε activity is likely
regulated at the level of mRNA induction and not at the level
of phosphorylation by stimuli-activated kinases (Shimada et al.,
1999; Kishore et al., 2002).
Phosphorylation is a fundamental mechanism of IRF protein
activation, necessary for nuclear translocation, dimerization,
binding to DNA and activation of transcription [Reviewed in
(Servant et al., 2001)]. Upon viral infection, both IRF-3 and
IRF-7 are phosphorylated within the C terminus of the protein
(Mamane et al., 1999). Although recent studies indicated that
IRF-3 may also be a phosphorylation target following
stimulation of cellular stress pathways or the engagement of
TLR receptors like TRL3 and 4 [Reviewed in (Servant et al.,
2002)], only Sendai Virus, Measles Virus, Newcastle Disease
Virus, VSV and RSV have been clearly shown to induce C-
terminal phosphorylation of IRF-3 (Servant et al., 2001; Casola
et al., 2001a; tenOever et al., 2002). Among the major viral-
inducible phosphoacceptor sites present in the C-terminal
portion of IRF-3, Ser396 has been shown to be the minimal
phosphoacceptor site involved in IRF-3 activation following
infection with Sendai virus and double-stranded RNA treatment
(Servant et al., 2003). Using a novel phosphospecific antibody
(Servant et al., 2003), we show that RSV infection induces
Ser396 phosphorylation, which is completely abolished by the
expression of catalytically inactive IKKε, indicating a funda-
mental role of this kinase in RSV-induced IRF-3 activation. The
evidence that IKKε, following RSV infection, is able to
phosphorylate a C-terminal IRF-3 peptide, containing the
major viral-inducible phosphoacceptor sites, with a kinetics
very similar to the kinetics of RSV-induced IRF-3 activation
(Casola et al., 2001a) strongly suggests that IKKε is a
component of the virus-activated kinase complex required for
IRF-3 phosphorylation following RSV infection. Since TBK1
has also been shown to play an important role in viral-induced
IRF-3 activation, we are currently investigating the contribution
of this kinase in IRF-3 activation following RSV infection.
In this study, we show that ROS formation plays a major role
in the signaling pathway leading to viral-induced IRF-3
activation. Antioxidant treatment blocks IKKε expression and
subsequent IRF-3 phosphorylation, following RSV infection,
identifying this pathway as redox-sensitive. This is a novel
observation, since it is the first time that viral-induced ROS
production are shown to be involved in IKKε activation and
subsequent IRF-3 phosphorylation. NF-κB could be the redox-
sensitive target involved in IKKε gene transcription, since ROS
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following various stimuli (Schieven et al., 1993; Schoonbroodt
and Piette, 2000). Intracellular ROS can be generated by
different systems, including the NAD(P)H oxidase system, the
mitochondrial electron transport chain and enzymes like
xanthine oxidase and cyclooxygenase. ROS play an important
role in the regulation of intracellular signaling cascades in
various cell types including fibroblasts, endothelial cells,
myocytes, smooth muscle cells, etc. [Reviewed in (Droge,
2002)]. In our study, treatment of RSV-infected alveolar
epithelial cells with a panel of inhibitors of the NAD(P)H
complex significantly reduced RANTES production and IRF-3
activation. DPI also almost completely abolishes viral-induced
IKKε gene expression. These data suggest that NAD(P)H
oxidase is an important system for the generation of ROS and
subsequent activation of IRF-3, following RSV infection. Since
inhibitors may not be completely specific for NAD(P)H
oxidase, current studies are in progress to better define the
role of this complex in RSV-induced ROS formation and IRF-3
activation. However, the recent finding that Rac1, a small
GTPase part of the NAD(P)H complex , is necessary for
influenza virus-induced activation of IRF-3 and IRF-3-depen-
dent genes (Ehrhardt et al., 2004), supports the role of NAD(P)
H-generated ROS as fundamental mediators of the viral-
induced signaling pathway leading to IRF-3 activation.
In summary, RSV-induced chemokine gene expression is
controlled by numerous ROS-sensitive signaling molecules.
This study indicates that viral-induced ROS formation,
occurring likely through the NAD(P)H oxidase-generated
system, is necessary for IRF-3 phosphorylation, through
modulation of IKKε activation, and identifies a novel molecular
target for the development of strategies aimed to modulate the
inflammatory response associated with RSV infection of the
lung.
Materials and methods
RSV preparation
The RSVA2 strain was grown in Hep-2 cells and purified by
centrifugation on discontinuous sucrose gradients as described
elsewhere (Ueba, 1978). The virus titer of the purified RSV
pools, was 8–9 log10 plaque forming units (PFU)/ml using a
methylcellulose plaque assay. No contaminating cytokines were
found in these sucrose-purified viral preparations (Patel et al.,
1995). LPS, assayed using the limulus hemocyanin agglutina-
tion assay, was not detected. Virus pools were aliquoted, quick-
frozen on dry ice/alcohol and stored at −70 °C until used.
Cell culture and infection of epithelial cells with RSV
A549, human alveolar type II-like epithelial cells, and 293, a
human embryonic kidney epithelial cell line (both from ATCC,
Manassas, VA), were maintained in F12K and MEM medium
respectively, containing 10% (v/v) FBS, 10 mM glutamine,
100 IU/ml penicillin and 100 μg/ml streptomycin. Cell
monolayers were infected with RSV at multiplicity of infection(MOI) of 3 (unless otherwise stated), as described (Garofalo
et al., 1996). An equivalent amount of a 30% sucrose solution
was added to uninfected A549 cells, as a control. When
inhibitors were used, cells were pretreated for 1 h and then
infected in the presence of the compound. Since inhibitors
were diluted either in ethanol or in DMSO, equal amount of
diluent was added to untreated cells, as a control. Total number
of cells and cell viability, following treatment, were measured
by trypan blue exclusion. No cell toxicity was observed for
any compound at concentrations used for the experiments.
Western blotting
Total cell lysates were prepared by adding ice-cold lysis
buffer (50 mM Tric–HCl, pH 7.4, 150 mM NaCl, 1 mM EGTA,
0.25% sodium deoxycholate, 1 mM Na3VO4, 1 mM NaF, 1%
Triton X-100 and 1 μg/ml of aprotinin, leupeptin and pepstatin.
After incubation on ice for 10 min, the lysates were collected
and detergent insoluble materials were removed by centrifuga-
tion at 4 °C at 14,000 × g. Cytoplasmic and nuclear extracts
were prepared using hypotonic/nonionic detergent lysis, as
previously described (Casola et al., 2000). Proteins (20 to 50 μg
per sample) were then boiled in 2× Laemmli buffer for 2 min
and resolved on SDS-PAGE. Proteins were transferred for 6 h
onto Hybond-ECL nitrocellulose membrane (Amersham Phar-
macia Biotech) and nonspecific binding sites were blocked by
immersing the membrane in TBST blocking solution [10 mM
Tris–HCl, pH 7.6, 150 mM NaCl, 0.05% Tween-20 (v/v)]
containing 5% skim milk powder or 5% bovine serum albumin
for 30 min. After a short wash in TBST, the membranes were
incubated with the primary antibody overnight at 4 °C, followed
by an anti-rabbit peroxidase-conjugated secondary antibody
(Santa Cruz Biotechnology), diluted 1:10,000 in TBST for
30 min at room temperature. After washing, the proteins were
detected using ECL (Amersham Pharmacia Biotech) according
to manufacturer's protocol. The primary antibodies used for
Western blots were: rabbit anti-IKKε polyclonal (Millennium
Pharmaceutical), rabbit polyclonal antibody to phospho-IRF-3,
which recognize the viral-induced C-terminal phosphorylated
form of the molecule (Servant et al., 2003), (a gift from
Rongtuan Lin, McGill University, Montreal, Canada), rabbit
polyclonal antibodies against IRF-3 (Santa Cruz).
RANTES ELISA
Immunoreactive RANTES was quantified by a double
antibody ELISA kit (DuoSet, R&D Systems, Minneapolis,
MN) following the manufacturer's protocol.
Northern blot and real time PCR
Total RNA was extracted from control and infected A549
cells by the acid guanidium thiocyanate-phenol chloroform
method (Chomczynski and Sacchi, 1987). Twenty micrograms
of RNAwere fractionated on a 1.2% agarose-formaldehyde gel,
transferred to nylon membranes and hybridized to a radiola-
beled RANTES cDNA, as previously described (Casola et al.,
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diography using Kodak XAR film at −70 °C, using intensifying
screens. After exposure, membranes were stripped and
rehybridized with a β-actin probe. For IKKε amplification by
real time PCR, Quantitative Real Time PCR (Q-RT-PCR)
Applied Biosystems assays-on-demand 20× mix of primers and
TaqMan MGB probes (FAM-dye labeled) for target genes and
18S rRNA (VIC-dye labeled probe) TaqMan assay reagent (P/N
4319413E) for controls were used. Separate tubes (singleplex)
one-step RT-PCR was performed with 80 ng RNA for both
target genes and endogenous control. The cycling parameters
for one-step RT-PCRwas: reverse transcription 48 °C for 30min,
AmpliTaq activation 95 °C for 10 min, denaturation 95 °C for
15 s and annealing/extension 60 °C for 1 min (repeat 30 times)
on ABI7000. Duplicate CT values were analyzed in Microsoft
Excel using the comparative CT (ΔΔCT) method as described
by the manufacturer (Applied Biosystems). The amount of
target (2−ΔΔCT) was obtained by normalizing to endogenous
reference (18S) sample.
Plasmid construction and cell transfection
The PGL2-220 plasmid, containing the first 220 nucleotides
of the RANTES promoter, the IL-8 LUC, containing the first
−162 nucleotides of the IL-8 promoter, as well as the plasmid
containing multiple copies of the RANTES ISRE site linked to
the luciferase reporter gene, have been previously described
(Casola et al., 2000, 2001b, 2002). The IKKε wild type and
catalytically-inactive (K38A) plasmids were created by cloning
the PCR product corresponding to bases 324 to 2477 of the
human IKKε gene into the pcDNA3 expression vector, using
the BamHI and XbaI cloning sites, as previously described
(Peters et al., 2000). Mutation of the lysine 38 residue to alanine
was introduced by overlapping PCR (Peters et al., 2000). The
plasmid expressing a kinase inactive (DN) IKKβ was a
generous gift of Dr. Mercurio, Signal Pharmaceutics, and has
been previously described (Mercurio et al., 1997).
Logarithmically growing A549 or 293 cells were trans-
fected in triplicate in 60 mm dishes using Fugene 6 (Roche,
Indianapolis, Ind.). One μg of the reporter gene plasmid,
0.5 μg of β-galactosidase and 0.5 μg of either IKKε wild type
or K38A or IKKβ DN expression plasmid were premixed with
FuGene6 in a 1:3 ratio (μg/μl), and added to the cells in 3 ml
of regular medium. The next morning, cells were infected with
RSV and at 12 or 24 h post-infection cells were lysed to
measure independently luciferase and β-galactosidase reporter
activity, as previously described (Casola et al., 2000).
Luciferase was normalized to the internal control β-galacto-
sidase activity. All experiments were performed at least two to
three times.
IKKε stable cell lines
Tetracycline-inducible 293-IKKε wild type and kinase
inactive cell lines were generated using a modified version of
the Tet-on system (Yamamoto et al., 2001). 293T cells were
transfected with plasmids encoding a reverse tetracycline-inducible transactivator, a tetracycline-regulated repressor, the
puromycin resistance gene and IKKε (wild type or K38A
mutant) and GFP under the control of a bi-directional promoter
(plasmids were kindly provided by Dr. Jay Morgenstern,
Millennium Pharmaceuticals). Transfection was performed
using Fugene 6, according to the manufacturer's instructions.
Stably transfected cell lines were selected in the presence of
puromycin. Flow cytometry sorting was used to select cells that
were GFP-negative in the absence of doxycycline and GFP-
positive in its presence. Cells were sorted as single cells into 96-
well plates and resulting clones were tested for inducible IKKε
protein expression by Western blot analysis.
Kinase assays
A549 cells were resuspended in lysis buffer [25 mM Tris, pH
7.5, 150 mM NaCl, 1.0% Triton X-100, 10.0% Glycerol. 1 mM
DTT, 20 mM β-glycerolphosphate, 0.2 mM sodium orthova-
nadate, 20 mM p-Nitrophenyl phosphate (PNPP), 1 mM PMSF,
1 mM Benzamidine supplemented with 1 mini protease
inhibitor tablet per 10 ml (ROCHE)]. Lysates were cleared by
centrifugation at 14,000 rpm for 10 min at 4 °C. 0.5 mg protein
lysate was incubated for 3 h at 4° with 7.5 mg of IgG-purified
anti-IKKε antibody, followed by 1 h incubation at 4° with 20 ml
of protein G slurry (Amersham). Samples were rotated end-
over-end during all incubations. Protein G beads were pre-
blocked and equilibrated with lysis buffer containing 0.2 mg/ml
BSA. After the immunoprecipitation, the beads were collected
by centrifugation for 3 min at 6,000 rpm and washed twice with
lysis buffer. Kinase assays with biotinylated IRF-3 peptide aa
380–406 (GGASSLENTVDLHISNSHPLSLTSDQ) as sub-
strate were performed out in a total volume of 10 ml in kinase
buffer containing 100mMATP, 1.0mg of substrate and 0.33 μCi
of 32P-γATP. The reaction was carried out for 30 min at 37° and
was terminated by addition of 20 ml of 7.5 M guanidine
hydrochloride. The phosphorylated substrate was spotted on
SAM2, a biotin capture membrane (Promega, Madison, WI).
Filters were washed several times with 2 M NaCl solution and
phosphorylated substrate was visualized and analyzed by
PhosphoImager after overnight exposure.
Note added in proof
While the manuscript was in revision, Chiang et al.
published that LPS-induced IRF-3 activation also occurs
through NADPH-mediated ROS formation (Journal of Immu-
nology 2006, 176:5720–24).
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